These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17487742)

  • 21. Purinergic receptor expression in the regeneration epidermis in a rat model of normal and delayed wound healing.
    Greig AV; James SE; McGrouther DA; Terenghi G; Burnstock G
    Exp Dermatol; 2003 Dec; 12(6):860-71. PubMed ID: 14714568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B-cell acute lymphoblastic leukemia.
    Dou H; Chen X; Huang Y; Su Y; Lu L; Yu J; Yin Y; Bao L
    Genes Chromosomes Cancer; 2017 Feb; 56(2):135-146. PubMed ID: 27637012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
    Bendall LJ; Bradstock KF; Gottlieb DJ
    Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of transforming growth factor-β1 expression in leukemia and its possible role in leukemia development.
    Wu Y; Chen P; Huang HF; Huang MJ; Chen YZ
    Leuk Lymphoma; 2012 Jan; 53(1):145-51. PubMed ID: 21740305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.
    Strassheim D; Verin A; Batori R; Nijmeh H; Burns N; Kovacs-Kasa A; Umapathy NS; Kotamarthi J; Gokhale YS; Karoor V; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
    Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
    Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of vascular smooth muscle nuclear factor kappa-B by G alpha q-coupled and cytokine receptors.
    Abbott KL; Robida AM; Davis ME; Pavlath GK; Camden JM; Turner JT; Murphy TJ
    J Mol Cell Cardiol; 2000 Mar; 32(3):391-403. PubMed ID: 10731439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells.
    Kawagoe H; Humphries RK; Blair A; Sutherland HJ; Hogge DE
    Leukemia; 1999 May; 13(5):687-98. PubMed ID: 10374871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression.
    Shah K; Moharram SA; Kazi JU
    Clin Epigenetics; 2018; 10():83. PubMed ID: 29951132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinase-activated receptors, nucleotide P2Y receptors, and μ-opioid receptor-1B are under the control of the type I transmembrane proteins p23 and p24A in post-Golgi trafficking.
    Luo W; Wang Y; Reiser G
    J Neurochem; 2011 Apr; 117(1):71-81. PubMed ID: 21219331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy.
    Alves M; Gomez-Villafuertes R; Delanty N; Farrell MA; O'Brien DF; Miras-Portugal MT; Hernandez MD; Henshall DC; Engel T
    Epilepsia; 2017 Sep; 58(9):1603-1614. PubMed ID: 28733972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
    Benito J; Ramirez MS; Millward NZ; Velez J; Harutyunyan KG; Lu H; Shi YX; Matre P; Jacamo R; Ma H; Konoplev S; McQueen T; Volgin A; Protopopova M; Mu H; Lee J; Bhattacharya PK; Marszalek JR; Davis RE; Bankson JA; Cortes JE; Hart CP; Andreeff M; Konopleva M
    Clin Cancer Res; 2016 Apr; 22(7):1687-98. PubMed ID: 26603259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The G protein-coupled receptor P2RY8 and follicular dendritic cells promote germinal center confinement of B cells, whereas S1PR3 can contribute to their dissemination.
    Muppidi JR; Lu E; Cyster JG
    J Exp Med; 2015 Dec; 212(13):2213-22. PubMed ID: 26573295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells.
    Resende RR; Britto LR; Ulrich H
    Int J Dev Neurosci; 2008 Nov; 26(7):763-77. PubMed ID: 18675894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
    Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
    J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No prognostic impact of P2RY8-CRLF2 fusion in intermediate cytogenetic risk childhood B-cell acute lymphoblastic leukaemia.
    Krawczyk J; Haslam K; Lynam P; Kelly J; Storey L; O'Marcaigh A; Langabeer SE; Smith OP
    Br J Haematol; 2013 Feb; 160(4):555-6. PubMed ID: 23145900
    [No Abstract]   [Full Text] [Related]  

  • 37. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes.
    Clifford EE; Martin KA; Dalal P; Thomas R; Dubyak GR
    Am J Physiol; 1997 Sep; 273(3 Pt 1):C973-87. PubMed ID: 9316419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid resensitization of purinergic receptor function in human platelets.
    Mundell SJ; Barton JF; Mayo-Martin MB; Hardy AR; Poole AW
    J Thromb Haemost; 2008 Aug; 6(8):1393-404. PubMed ID: 18513210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of a constitutively active mutant of JAK3 by retroviral expression screening.
    Choi YL; Kaneda R; Wada T; Fujiwara S; Soda M; Watanabe H; Kurashina K; Hatanaka H; Enomoto M; Takada S; Yamashita Y; Mano H
    Leuk Res; 2007 Feb; 31(2):203-9. PubMed ID: 16790275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of purinergic P2Y receptor subtypes by INS-1 insulinoma beta-cells: a molecular and binding characterization.
    Lugo-Garcia L; Filhol R; Lajoix AD; Gross R; Petit P; Vignon J
    Eur J Pharmacol; 2007 Jul; 568(1-3):54-60. PubMed ID: 17509560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.